Cancer Prevention
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 13, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Juliana Gil Melgaço1, Noemi Rovaris Gardinali2, Vinicius da Motta de Mello1
1Ambulatório/Laboratório de Hepatites Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
Hepatitis E virus (HEV) infection is a global health concern. While vaccines and treatments like ribavirin exist, further research is needed to establish their worldwide importance in public health strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: